Vanderbilt University Medical Center
2015 - Fellow of the American Association for the Advancement of Science (AAAS)
His main research concerns Lung cancer, Cancer research, Pathology, Cancer and Lung. His research integrates issues of Carcinogenesis and Cohort in his study of Lung cancer. His Cancer research study incorporates themes from Mutation, Gene mutation, Signal transduction, Exon and Rovalpituzumab tesirine.
His Pathology study integrates concerns from other disciplines, such as Biomarker, Proteomics and Adenocarcinoma. His Cancer research incorporates elements of Survival rate, Carcinoma, Immunology and Hazard ratio. His Lung research is multidisciplinary, incorporating elements of Frozen section procedure and Receiver operating characteristic.
Pierre P. Massion mostly deals with Lung cancer, Cancer research, Internal medicine, Cancer and Pathology. His research in Lung cancer intersects with topics in Biomarker, Radiology, Lung and Early detection. His research integrates issues of Non small cell, Small Cell Lung Carcinoma, Cell growth, Metastasis and Adenocarcinoma in his study of Cancer research.
Pierre P. Massion has included themes like Gastroenterology, Endocrinology and Oncology in his Internal medicine study. His research investigates the connection with Cancer and areas like Immunology which intersect with concerns in COPD. His research in Pathology tackles topics such as Proteomics which are related to areas like Bioinformatics.
Lung cancer, Cancer research, Lung, Internal medicine and Lung cancer screening are his primary areas of study. His work carried out in the field of Lung cancer brings together such families of science as Retrospective cohort study, Emergency medicine, Confidence interval, Radiology and Tumor progression. The concepts of his Cancer research study are interwoven with issues in Cell growth, Autoantibody, Small hairpin RNA, Non small cell and Adenocarcinoma.
In his research on the topic of Lung, Computed tomographic, Prostate, Noninvasive biomarkers and Diagnostic biomarker is strongly related with Nodule. His Internal medicine study combines topics in areas such as Gastroenterology and Oncology. Pierre P. Massion studied Cohort and Cancer that intersect with CD8.
His scientific interests lie mostly in Lung cancer, Lung, Internal medicine, Cancer research and Lung cancer screening. His Lung cancer study incorporates themes from Retrospective cohort study, Confidence interval, Tumor progression, Qualitative feedback and Receiver operating characteristic. His Lung research is multidisciplinary, incorporating perspectives in Normal results, Curative treatment and Emergency medicine.
Pierre P. Massion works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Human genetics and Non invasive. His Cancer research research includes elements of Cell growth, NEUROD1, ASCL1, Small hairpin RNA and Genetically Engineered Mouse. The various areas that Pierre P. Massion examines in his Lung cancer screening study include Odds ratio, Guideline and Family medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
Kristin Bergethon;Alice T. Shaw;Sai Hong Ignatius Ou;Ryohei Katayama.
Journal of Clinical Oncology (2012)
Comprehensive genomic profiles of small cell lung cancer
Julie George;Jing Shan Lim;Se Jin Jang;Yupeng Cun.
The national lung screening trial: Overview and study design
Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black.
Proteomic patterns of tumour subsets in non-small-cell lung cancer.
Kiyoshi Yanagisawa;Yu Shyr;Baogang J Xu;Pierre P Massion.
The Lancet (2003)
Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer
Joseph Amann;Shailaja Kalyankrishna;Pierre P. Massion;Joyce E. Ohm.
Cancer Research (2005)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Charles M. Rudin;John T. Poirier;Lauren Averett Byers;Caroline Dive.
Nature Reviews Cancer (2019)
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.
Nicholas J. Wang;Zachary Sanborn;Kelly L. Arnett;Laura J. Bayston.
Proceedings of the National Academy of Sciences of the United States of America (2011)
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
Laura R. Saunders;Alexander J. Bankovich;Wade C. Anderson;Monette A. Aujay.
Science Translational Medicine (2015)
Mass Spectrometry to Classify Non–Small-Cell Lung Cancer Patients for Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Multicohort Cross-Institutional Study
Fumiko Taguchi;Benjamin Solomon;Vanesa Gregorc;Heinrich Roder.
Journal of the National Cancer Institute (2007)
Significance of p63 amplification and overexpression in lung cancer development and prognosis.
Pierre P. Massion;Peter M. Taflan;S. M. Jamshedur Rahman;Pinar Yildiz.
Cancer Research (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: